Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	75.32B
Revenue (ttm)	42.23B
Net Income (ttm)	3.56B
Shares Out	1.75B
EPS (ttm)	2.03
PE Ratio	21.18
Forward PE	18.59
Dividend	1.16 (2.64%)
Ex-Dividend Date	Jun 5, 2025

Volume	12,282,928
Average Volume	15,230,327
Open	44.30
Previous Close	44.00
Day's Range	42.82 - 44.30
52-Week Range	26.96 - 46.00
Beta	0.47
RSI	55.24
Earnings Date	Aug 20, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 18,265
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.